Nutrition in the Neoadjuvant Gastric Cancer Patient, is early administration appropriate?

Nutrition in the Neoadjuvant Gastric Cancer Patient




nutrition, gastric cancer, enteral feeding, neoadjuvant nutrition



Purpose: Gastric cancer is one of the world's leading cancers. Despite the availability of testing, patients often present with advanced (stage III or stage IV) gastric cancer. These patients are always in a state of malnutrition and will be sarcopenic secondary to pain, loss of appetite, nausea, vomiting and dysphagia. Treatment for this cancer includes radical surgery, sometimes chemotherapy and rarely radiotherapy. It is already well documented that nutrition is critical to patient outcomes during chemotherapy, surgery and healing; because of this, many measures are already in place to improve nutrition in these patients. This literature review will look directly at the use of enteral feeding (EN) of gastric cancer patients prior to or in conjunction with neoadjuvant chemotherapy (NACT).

Methods: Research was focused on the keywords: nutrition, gastric cancer, enteral feeding and neoadjuvant nutrition. Several electronic journals were reviewed, National Center for Biotechnology Information (NCBI), PubMed, QxMD Read, Science Direct, as well, a search was conducted through Alberta Health Services Knowledge Resource Service (KRS).

Results: The combined information within each of the articles reviewed all recognized that early nutrition supplementation had positive impacts on maintaining albumin levels, an increase in the patient's immunity, improved healing and shortened length of hospital stay.

Conclusion: All patients receive nutrition throughout their hospital stay; research indicates that the earlier nutrition is given to a patient, the better the overall outcomes of chemotherapy, surgery, shortened length of stay, and quality of life.

Keywords: nutrition, gastric cancer, enteral feeding and neoadjuvant nutrition.



Wu C, Chi C, Lin W. Gastric cancer: Prognostic and diagnostic advances. Expert Reviews in Molecular Medicine. 2002;4(6):1-12. Accessed May 9, 2020.

Orditura M, Galizia G, Sforza V, et al. Treatment of gastric cancer. World Journal of Gastroenterology. 2014;20(7):1635-1649.

Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition. 2017;36(1):11-48. Accessed Aug 16, 2020.

Wild T, Rahbarnia A, Kellner M, Sobotka L, Eberlein T. Basics in nutrition and wound healing. Nutrition. 2010;26(9):862-866. Accessed Jun 11, 2020.

Barchitta M, Maugeri A, Favara G, et al. Nutrition and wound healing: An overview focusing on the beneficial effects of curcumin. International Journal of Molecular Science. 2019;20(5).

Jeejeebhoy K. Canadian malnutrition task force

. Updated 2020. Accessed -08-12, 2020.

Jager-Wittenaar H, Ottery FD. Assessing nutritional status in cancer: Role of the patient-generated subjective global assessment. Current Opinion in Clinical Nutrition & Metabolic Care. 2017;20(5):322–329. Accessed Aug 12, 2020.

Wakabayashi H. Rehabilitation nutrition in general and family medicine. Journal of General and Family Medicine. 2017;18(4):153-154. Accessed Aug 12, 2020.

Migita, K., Matsumoto, S., Wakatsuki, K. et al. A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy. Surgery Today. 2017(47):1018–1026.

Jankowski M, Las-Jankowska M, Sousak M, Zegarski W. Contemporary enteral and parenteral nutrition before surgery for gastrointestinal cancers: A literature review. World J Surg Oncol. 2018;16. Accessed Aug 18, 2020.

Parent BA, Seaton M, Djukovic D, et al. Parenteral and enteral nutrition in surgical critical-care: Plasma metabolomics demonstrates divergent effects on nitrogen, fatty-acid, ribonucleotide and oxidative metabolism. J Trauma Acute Care Surg. 2017;82(4):704-713. Accessed Aug 13, 2020.

Zhao X, Wu N, Zhao G, Liu J, Dai Y. Enteral nutrition versus parenteral nutrition after major abdominal surgery in patients with gastrointestinal cancer: A systematic review and meta-analysis. J Investig Med. 2016;64(5):1061-1074. Accessed Aug 13, 2020.

Choi AH, O'Leary MP, Merchant SJ, et al. Complications of feeding jejunostomy tubes in patients with gastroesophageal cancer. J Gastrointest Surg. 2017;21(2):259-265. Accessed Aug 25, 2020.

Miyata H, Yano M, Yashuda T, et al. Randomized study of the clinical effects of ω-3 fatty acid–containing enteral nutrition support during neoadjuvant chemotherapy on chemotherapy-related toxicity in patients with esophageal cancer. January 17;33:204-210.

Mueller T, Schirren R, Kehl V, Friess H, Reim D, Martignoni M. Parenteral nutrition during neoadjuvant chemotherapy for patients with non-metastatic gastric or esophago-gastric cancer to reduce postoperative morbidity (PERCOG): Study protocol for a randomized controlled trial. BMC. 2017.

Rosania R, Chiapponi C, Malfertheiner P, Venerito M. Nutrition in patients with gastric cancer: An update. GAT. 2015;2(4):178-187. Accessed Aug 25, 2020.

Fan C, Li G, Li N, Li J. Nutritional support in progressive gastric cancer patients with obstruction during the neoadjuvant chemothearpy. CNKI. 2008.

Sun Y, Xu X, Hu J, et al. [Efficacies of neoadjuvant chemotherapy plus nutritional support in advanced gastric cancer complicated with pylori obstruction]. Zhonghua Yi Xue Za Zhi. 2014;94(8):584-586. Accessed Aug 17, 2020.



How to Cite

Stringfellow, DMSc CCPA CD, P. (2021). Nutrition in the Neoadjuvant Gastric Cancer Patient, is early administration appropriate? : Nutrition in the Neoadjuvant Gastric Cancer Patient. The Journal of Canada’s Physician Assistants, 3(8), 28–35.